413 related articles for article (PubMed ID: 28743274)
1. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.
Kuroda K; Yamamoto Y; Yanagisawa M; Kawata A; Akiba N; Suzuki K; Naritaka K
BMC Womens Health; 2017 Jul; 17(1):50. PubMed ID: 28743274
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study.
Hareyama H; Hada K; Goto K; Watanabe S; Hakoyama M; Oku K; Hayakashi Y; Hirayama E; Okuyama K
Int J Gynecol Cancer; 2015 May; 25(4):751-7. PubMed ID: 25723779
[TBL] [Abstract][Full Text] [Related]
3. Complications of lymphadenectomy for gynecologic cancer.
Achouri A; Huchon C; Bats AS; Bensaid C; Nos C; Lécuru F
Eur J Surg Oncol; 2013 Jan; 39(1):81-6. PubMed ID: 23117018
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies.
Graf N; Rufibach K; Schmidt AM; Fehr M; Fink D; Baege AC
Eur J Gynaecol Oncol; 2013; 34(1):23-7. PubMed ID: 23589994
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy.
Deura I; Shimada M; Hirashita K; Sugimura M; Sato S; Sato S; Oishi T; Itamochi H; Harada T; Kigawa J
Int J Clin Oncol; 2015 Jun; 20(3):556-60. PubMed ID: 24993674
[TBL] [Abstract][Full Text] [Related]
6. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer.
Biglia N; Librino A; Ottino MC; Panuccio E; Daniele A; Chahin A
Int J Gynecol Cancer; 2015 Mar; 25(3):521-5. PubMed ID: 25621410
[TBL] [Abstract][Full Text] [Related]
7. Incidence of lymphedema in the lower limbs and lymphocyst formation within one year of surgery for endometrial cancer: A prospective longitudinal multicenter study.
Wedin M; Stålberg K; Marcickiewicz J; Ahlner E; Åkesson Å; Lindahl G; Kjølhede P;
Gynecol Oncol; 2020 Oct; 159(1):201-208. PubMed ID: 32763108
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with response to compression-based physical therapy for secondary lower limb lymphedema after gynecologic cancer treatment: a multicenter retrospective study.
Yoshihara M; Kitamura K; Tsuru S; Shimono R; Sakuda H; Mayama M; Tano S; Uno K; Ukai MO; Kishigami Y; Oguchi H; Hirota A
BMC Cancer; 2022 Jan; 22(1):25. PubMed ID: 34980013
[TBL] [Abstract][Full Text] [Related]
9. Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.
Lindqvist E; Wedin M; Fredrikson M; Kjølhede P
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():112-121. PubMed ID: 28242470
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
11. Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection.
Kim SI; Lim MC; Lee JS; Lee Y; Park K; Joo J; Seo SS; Kang S; Chung SH; Park SY
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():31-6. PubMed ID: 26142914
[TBL] [Abstract][Full Text] [Related]
12. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience.
Volpi L; Sozzi G; Capozzi VA; Ricco' M; Merisio C; Di Serio M; Chiantera V; Berretta R
Int J Gynecol Cancer; 2019 Feb; 29(2):312-319. PubMed ID: 30718312
[TBL] [Abstract][Full Text] [Related]
13. Identifying risk factors for occult lower extremity lymphedema using computed tomography in patients undergoing lymphadenectomy for gynecologic cancers.
Kim M; Suh DH; Yang EJ; Lim MC; Choi JY; Kim K; No JH; Kim YB
Gynecol Oncol; 2017 Jan; 144(1):153-158. PubMed ID: 28094037
[TBL] [Abstract][Full Text] [Related]
14. Large or persistent lymphocyst increases the risk of lymphedema, lymphangitis, and deep vein thrombosis after retroperitoneal lymphadenectomy for gynecologic malignancy.
Kondo E; Tabata T; Shiozaki T; Motohashi T; Tanida K; Okugawa T; Ikeda T
Arch Gynecol Obstet; 2013 Sep; 288(3):587-93. PubMed ID: 23455541
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of undiagnosed postoperative lower limb lymphedema among gynecological oncology patients.
Wong M; Eaton PK; Zanichelli C; Moore C; Hegarty C; MacDonald N
Eur J Surg Oncol; 2022 May; 48(5):1167-1172. PubMed ID: 34980543
[TBL] [Abstract][Full Text] [Related]
16. Lower-extremity lymphedema following management for endometrial and cervical cancer.
Mendivil AA; Rettenmaier MA; Abaid LN; Brown JV; Micha JP; Lopez KL; Goldstein BH
Surg Oncol; 2016 Sep; 25(3):200-4. PubMed ID: 27566023
[TBL] [Abstract][Full Text] [Related]
17. Impact on lower limb lymphedema of pelvic lymphadenectomy with external iliac lymph nodes left-opened distal lymphatics technique.
Zeng W; Wang R; Ying W; Xu W; Zhao X
Int Angiol; 2021 Apr; 40(2):143-149. PubMed ID: 33300763
[TBL] [Abstract][Full Text] [Related]
18. Does initial routine use of a compression garment reduce the risk of lower limb lymphedema after gynecological cancer treatment? A randomized pilot study in an Asian institution and review of the literature.
Hnin YK; Ong LX; Tsai CC; Ong SS; Yee SG; Choo BA; Low JJ
Lymphology; 2018; 51(4):174-183. PubMed ID: 31119907
[TBL] [Abstract][Full Text] [Related]
19. [Postoperative administration of octreotide to reduce lymphorrhea, lymphocele, lymphedema and lymphatic ascites after lymphadenectomy in gynecological malignancies].
Weinberger V; Minář L; Felsinger M; Seidlová D; Ovesná P; Bednaříková M; Jandáková E; Rovný I
Ceska Gynekol; 2017; 82(2):92-99. PubMed ID: 28585840
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment.
Kunitake T; Kakuma T; Ushijima K
Int J Clin Oncol; 2020 May; 25(5):963-971. PubMed ID: 31907719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
